Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/01/1990 | WO1990012874A2 Cysteine added variants of polypeptides and chemical modifications thereof |
11/01/1990 | WO1990012594A1 Novel monoclonal antibody to novel antigen associated with human tumors |
11/01/1990 | WO1990012583A1 Pharmaceutical compositions |
11/01/1990 | WO1990012576A1 Liquid prostaglandin composition |
11/01/1990 | WO1990012571A1 Compositions and methods for administering vitamin c |
10/31/1990 | EP0394928A1 Topical antiviral pharmaceutical composition containing a nonionic surfactant |
10/31/1990 | EP0394881A2 Radiation sterilizable antimicrobial ointment and process to manufacture |
10/31/1990 | EP0394731A1 Method for preparation of mixtures of xanthan and cellulose derivatives |
10/31/1990 | EP0394277A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
10/31/1990 | DE4011956A1 Verfahren und vorrichtung zur darstellung von sterilen einspritzbaren antibiotikapulvern Method and device for presentation of sterile injectable antibiotic powders |
10/31/1990 | CN1046464A Method for reducing side effects of drug |
10/30/1990 | US4966903 Injectable |
10/30/1990 | US4966899 Antibacterial lyophilized preparation of aspoxicillin |
10/30/1990 | US4966774 Antiinflammtory agents, a remedy for cardiac disorder, storage stability |
10/30/1990 | US4966768 Sustained release etodolac |
10/30/1990 | US4966577 Prevention of lens-related tissue growth in the eye |
10/30/1990 | CA1275626C Use of lupinus sues powder in the manufacture of cosmetic or dermopharmaceutical compositions, and compositiond containing the same |
10/28/1990 | WO1990012597A1 Fibroblast growth factor conjugates |
10/27/1990 | CA2012727A1 Process and an apparatus for the preparation of sterile injectable powders of antibiotics |
10/26/1990 | WO1990012868A1 Antibodies specific for cd4-binding domain of hiv |
10/26/1990 | CA2051107A1 Antibodies specific for cd4-binding domain of hiv |
10/26/1990 | CA2015427A1 Pharmaceutical composition for topical ophthalmic use having improved local tolerability |
10/24/1990 | EP0394045A2 Cyclophosphamide lyophilizates |
10/24/1990 | EP0394026A1 Formulation containing an imidazo[4,5-c]quinolin derivative |
10/24/1990 | EP0394022A1 Calcium pantothenate composit |
10/24/1990 | EP0393973A1 Antitumor Agent Indicated for lung cancer |
10/24/1990 | EP0393904A2 Moisturising vehicle for topical application of vitamin a acid |
10/24/1990 | EP0393890A1 Injectable compositions containing 25-cyclohexyl-avermectin B1 |
10/24/1990 | EP0393727A2 Transdermal delivery system |
10/24/1990 | EP0393575A1 Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent |
10/24/1990 | EP0393572A2 Controlled release tablets containing flavoxate |
10/24/1990 | EP0393537A2 Granulation product of calcium ascorbate |
10/24/1990 | EP0393164A1 Topical delivery system |
10/24/1990 | CN1046333A Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing methyle-trithio group, and targeted forms thereof |
10/24/1990 | CN1046282A Antiparasitic formulations |
10/24/1990 | CA2015206A1 Topical antiviral pharmaceutical composition containing a nonionic surfactant |
10/23/1990 | US4965357 2,5,6-substituted N1 -alkylpyrimidines |
10/23/1990 | US4965353 Polysaccharide esters and their salts |
10/23/1990 | US4965347 Beta-D-glucan, and its production and uses |
10/23/1990 | US4965253 Viscoelastic material for ophthalmic surgery |
10/23/1990 | US4965252 Cholesterol-lowering combination compositions of guar gum and niacin |
10/23/1990 | US4965203 Purified thrombin preparations |
10/23/1990 | US4965072 Granulating composition and method |
10/22/1990 | WO1990012592A1 Recombinant antibody-toxin fusion protein |
10/20/1990 | WO1990013540A1 Active carbonates of polyalkylene oxides for modification of polypeptides |
10/20/1990 | CA2014926A1 Oral preparation |
10/19/1990 | WO1990012595A1 Liposomal targeting of ischemic tissue |
10/18/1990 | WO1990012572A1 Stable ascorbic acid compositions |
10/18/1990 | WO1990012109A1 Monoclonal antibodies binding platinum complexes |
10/18/1990 | WO1990012096A1 Method for enhancing transmembrane transport of exogenous molecules |
10/18/1990 | WO1990012095A1 Method for enhancing transmembrane transport of exogenous molecules |
10/18/1990 | WO1990011781A1 The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions |
10/18/1990 | WO1990011779A1 Heteroconjugates |
10/18/1990 | WO1990011757A1 Sustained-release oral drug dosage form |
10/18/1990 | WO1990011734A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
10/18/1990 | WO1990011695A1 Novel n-(sulfomethyl)-n'-arylureas |
10/18/1990 | CA2014679A1 Antitumor agent indicated for lung cancer |
10/17/1990 | EP0392845A2 Solid gel external drug delivery system |
10/17/1990 | EP0392745A2 Immunoconjugates and prodrugs and their use in association for drug delivery |
10/17/1990 | EP0392717A1 Pharmaceutical formulations containing immunoglobulin conjugates |
10/17/1990 | EP0392608A2 Solid consumer product compositions containing small particle cyclodextrin complexes |
10/17/1990 | EP0392487A2 Stabilized composition of anthracyclines |
10/17/1990 | EP0392429A1 Psoralen-reagens |
10/17/1990 | EP0392384A2 Targeted forms of methyltrithio antitumor agents |
10/17/1990 | EP0391893A1 Porous microspheres for drug delivery and methods for making same. |
10/17/1990 | EP0182007B1 Galenical form containing nifedipine, and process for its preparation |
10/17/1990 | EP0173729B1 Process for solubilizing active principles and pharmaceutical compositions thus obtained |
10/17/1990 | CN1046169A Destructurized starch and making same |
10/17/1990 | CN1046097A Spray gel base and spray gel prepartion using thereof |
10/17/1990 | CA2014732A1 Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent |
10/17/1990 | CA2014437A1 Moisturizing vehicle for topical application of vitamin a acid |
10/17/1990 | CA2014304A1 Monoclonal antibody to novel anitgen associated with human tumors |
10/16/1990 | US4963656 Stable, retain moisture |
10/16/1990 | US4963556 Choline esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities |
10/16/1990 | US4963555 Formulations of heterocyclic compounds |
10/16/1990 | US4963551 Stable lyophilized form of (S)-(+)-bis-4,4'-(1-methyl-1,2-ethanediyl)2,6-piperazinedione and solutions thereof |
10/16/1990 | US4963525 Polypeptides |
10/16/1990 | US4963363 Phospholipid delivery vehicle for aqueous-insoluble active ingredients |
10/16/1990 | US4963345 Buffered acidic solution containing a vasodilator |
10/16/1990 | CA1275252C Effervescent acetylsalicylic acid tablets |
10/16/1990 | CA1275249C Composition containing essential fatty acids |
10/16/1990 | CA1275247C Process for the solubilization, at the time of use, of a lipophilic active principle in an aqueous solution for intravenous administration |
10/16/1990 | CA1275246C Process for preparing immunogenic complex |
10/14/1990 | CA2012543A1 Solid gel external drug delivery system |
10/13/1990 | CA2014470A1 Plasminogen activator complex of pure pro-urokinase covalently bound by a disulfide bridge to human serum albumin |
10/13/1990 | CA2014244A1 Stabilized composition of anthracyclines |
10/12/1990 | WO1990012029A1 Lyophilized peptide formulations |
10/12/1990 | CA2028848A1 Lyophilized peptide formulations |
10/11/1990 | WO1990012585A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
10/11/1990 | CA2028825A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
10/10/1990 | EP0391853A2 Destructurized starch and method of making same |
10/10/1990 | EP0391444A2 Interleukin-1 Formulation |
10/10/1990 | EP0391369A2 Medicinal emulsions |
10/10/1990 | EP0391342A1 Spray gel base and spray gel preparation using thereof |
10/10/1990 | EP0391088A2 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy |
10/10/1990 | EP0391002A2 Pharmaceutical compositions containing N-(3,4-dimethoxycinnamoyl) anthranilic acid |
10/10/1990 | EP0390930A1 Stable aqueous preparation of active vitamin d 3 |
10/10/1990 | EP0192660A4 Absorption enhancing agents |
10/10/1990 | CN1009931B Process for preparing glycerol ether phosphatides |
10/10/1990 | CN1009922B Method for prepn. of dobutamine salts |